Stenabolic (SR9009) is a PPAR alpha modifier drug that is still in development as of 2015. Its creator is professor Thomas Burris of the Scripps research institute. Interestingly, it is sold as a SARM and research chemical, and it can be compared to Cardarine (GW-501516), as it is also an agonist of Rev-ErbA.
According to an article by “National Medicine,” it enhances exercise capacity in mice by increasing mitochondria in skeletal muscle. This is why it has been marketed and hyped around the internet as “exercise in a bottle”.
Note; dosage information is only for scientific reference purposes. SARMs Central, does not condone the human consumption or use of this substance outside of a controlled scientific environment (i.e. a lab).
Stenabolic should be dosed at 20-30 milligrams (mg) per day and adjusted up or down by 10mg depending on user preference. Regarding the cycle duration, the typical cycle length is 6-8 weeks, and it would be wise to stack SR9009 with Cardarine (GW-501516) for a double dose of endurance power.
There is a big inconvenience with Stenabolic when compared to Cardarine, SR9009 does not have a long half life, so it is must be dosed 3-4 times per day. However, some forum members have had good success dosing it at 2-3 times per day.
Stenabolic (SR9009) will help a person become leaner, and it will help them do more distance with cardio without getting winded as fast. Overall, it will increase your VO2 max, allowing you to improve your endurance.
Additionally, SR9009 can benefit non athletes as well, since it can reverse obesity, metabolic syndrome, and type 2 diabetes.
Potential Side Effects
SR9009 does not act like a fat burner, thyroid accelerator, or appetite suppressant (such as clenbuterol, T3, or certain stimulants). Therefore, you won’t experience a crash or feel tired on it. However, due to the fact that Stenabolic is fairly new and hasn’t been used very much by human athletes, we are still waiting for more information on what kind of undesired effects it can possibly have.Find a distributor